Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies - PubMed (original) (raw)
Review
Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies
Jason Whitt et al. Curr Stem Cell Res Ther. 2016.
Abstract
Mesenchymal Stem/stromal cell (MSCs) transplantation procedures have been used since the 1960's to treat leukemia and other diseases, but due to the risks involved only patients with life threatening illnesses were typically subjected to the transplantation procedure until the last decade. Recent advancements in transplantation techniques have made it more feasible to use it for non-life-threatening diseases. However, the potential uses for stem cells are still limited by their rarity, and, in the case of allogeneic transplants, graft-vs.-host complications. An evolving alternative to conventional stem cell therapies is induced pluripotent stem-cell derived mesenchymal stem/stromal cells (iPSC- MSCs), which have a multi-lineage potential comparable to conventionally acquired MSCs with the added benefit of being less immunoreactive. However there are still many hurdles left to be overcome before they can be used regularly for personalized therapies. This review will focus on recent advancements that have been made regarding the role MSCs play in tumor development and the potential uses iPSC-MSCs may have in future cancer treatment.
Similar articles
- Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
Lin L, Bolund L, Luo Y. Lin L, et al. Curr Stem Cell Res Ther. 2016;11(2):122-30. doi: 10.2174/1574888x10666150723150236. Curr Stem Cell Res Ther. 2016. PMID: 26201862 - The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
Nakayama C, Fujita Y, Matsumura W, Ujiie I, Takashima S, Shinkuma S, Nomura T, Abe R, Shimizu H. Nakayama C, et al. J Dermatol Sci. 2018 Sep;91(3):301-310. doi: 10.1016/j.jdermsci.2018.06.004. Epub 2018 Jun 18. J Dermatol Sci. 2018. PMID: 29933899 - Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.
Yun YI, Park SY, Lee HJ, Ko JH, Kim MK, Wee WR, Reger RL, Gregory CA, Choi H, Fulcher SF, Prockop DJ, Oh JY. Yun YI, et al. Cytotherapy. 2017 Jan;19(1):28-35. doi: 10.1016/j.jcyt.2016.10.007. Epub 2016 Nov 10. Cytotherapy. 2017. PMID: 27840134 - Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review.
Vonk LA, de Windt TS, Slaper-Cortenbach IC, Saris DB. Vonk LA, et al. Stem Cell Res Ther. 2015 May 15;6(1):94. doi: 10.1186/s13287-015-0086-1. Stem Cell Res Ther. 2015. PMID: 25976213 Free PMC article. Review. - hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.
Sabapathy V, Kumar S. Sabapathy V, et al. J Cell Mol Med. 2016 Aug;20(8):1571-88. doi: 10.1111/jcmm.12839. Epub 2016 Apr 21. J Cell Mol Med. 2016. PMID: 27097531 Free PMC article. Review.
Cited by
- Comparative analysis of mesenchymal stem/stromal cells derived from human induced pluripotent stem cells and the cognate umbilical cord mesenchymal stem/stromal cells.
Wang Q, Wang Y, Chang C, Ma F, Peng D, Yang S, An Y, Deng Q, Wang Q, Gao F, Wang F, Tang H, Qi X, Jiang X, Cai D, Zhou G. Wang Q, et al. Heliyon. 2023 Jan 4;9(1):e12683. doi: 10.1016/j.heliyon.2022.e12683. eCollection 2023 Jan. Heliyon. 2023. PMID: 36647346 Free PMC article. - Current status of cardiac regenerative medicine; An update on point of view to cell therapy application.
Hassanpour M, Aghamohamadzade N, Cheraghi O, Heidarzadeh M, Nouri M. Hassanpour M, et al. J Cardiovasc Thorac Res. 2020;12(4):256-268. doi: 10.34172/jcvtr.2020.44. Epub 2020 Nov 24. J Cardiovasc Thorac Res. 2020. PMID: 33510874 Free PMC article. Review. - An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Wang D, Sun YQ, Gao WX, Fan XL, Shi JB, Fu QL. Wang D, et al. Cell Transplant. 2018 Sep;27(9):1340-1351. doi: 10.1177/0963689718780194. Epub 2018 Jul 30. Cell Transplant. 2018. PMID: 30056763 Free PMC article. - Different Effects of sgRNA Length on CRISPR-mediated Gene Knockout Efficiency.
Zhang JP, Li XL, Neises A, Chen W, Hu LP, Ji GZ, Yu JY, Xu J, Yuan WP, Cheng T, Zhang XB. Zhang JP, et al. Sci Rep. 2016 Jun 24;6:28566. doi: 10.1038/srep28566. Sci Rep. 2016. PMID: 27338021 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources